Cite
HARVARD Citation
Douglas, A. et al. (2022). [18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet. 9 (8), pp. e573-e584. [Online].